Logsdon et al have used data from the AMP-AD consortium to identify consensus gene clusters that are differentially expressed in Alzheimer’s disease.

The MODEL-AD consortium has worked with nanoString  to develop a transcriptomics panel to assay these modules in mouse models.

We expect that this will be a rapid, cost-effective and highly reproducible approach to assess clinical relevance of novel models, to monitor disease progression, and to assay potential therapeutics.  The transcriptomics panel is now available from nanoString.

 

Leave a Reply